Intervention and Control group patients who would have been considered compliant were 90-87%, 85-71%, 77-61%, 64-34%, 54-24%, respectively by category. Differences between the intervention and control groups increased with higher standards of compliance (ratios 1. 06, 1.22, 1.30, 1.92, 2.33) . In Study B, decreasing proportions of patients met criteria for compliance categories (56%, 50%, 44%, 35%, 26%, respectively). Changing categories affected regression models with the primary outcome. CONCLUSIONS: This exercise demonstrated the biases that occur when compliance is calculated by category because of lack of information to support selection of a category designating appropriate compliance. Information that would define a category below which a medication is ineffective is available for very few medications. Without such information, selection of a category as a determinant of medication compliance is inappropriate. This problem was removed by using continuous compliance data.
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CORRELATIONS BETWEEN A STAGE OF CHANGE MEASURE AND FOUR VALIDATED MEASURES OF MEDICATION COMPLIANCE
Cook CL, Perri III M University of Georgia, Athens, GA, USA OBJECTIVES: The literature contains a plethora of articles on medication compliance research, however, no "gold standard" in the measurement of compliance has been established. The Stage of Change (SOC) construct measure from the Transtheoretical Model of behavioral change has recently been validated in medication compliance. The objective of this study is to compare the SOC measure against Four other validated compliance measures in patients being treated for diabetes, hypertension, hypercholesterolemia, hypothyroidism, and hormone replace therapy. METHODS: A total of 171 male and female patients in five primary care physician offices in the state of Georgia, USA, completed a face-to-face questionnaire consisting of the SOC measure, the Medication Adherence Scale, the Medication Outcomes Survey (MOS) compliance question, the Brief Medication Compliance Questionnaire (BMQ) and sociodemographic information. Pharmacy refill records (RR) were collected as the fifth compliance measure. RESULTS: Pearson correlations ranged from a low of 0.09 between RR and BMQ to a high of 0.79 between SOC and MOS. All other correlations ranged between 0.20 and 0.49. All correlations proved significantly different than zero (p < 0.05) with the exception of the RR and BMQ correlation. CONCLUSIONS: The majority of correlations between validated measures of compliance ranged from weak to moderate in strength. Therefore the results of this study show selection of a useful compliance measure is difficult. The study findings emphasize that assessing medicationtaking behavior of patients and comparing the results of different compliance studies is problematic. The develop-
